Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH

NCT04540380 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Renal Failure

Interventions

DRUG: Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab
PROCEDURE: Combined bone marrow and kidney transplant

Sponsor

Massachusetts General Hospital